Clinical trial

Effect of Roflumilast at Acute Exacerbations of Chronic Obstructive Pulmonary Disease

NCT01473758

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2012-02-01

PhasePHASE2

Study timeline

Study start (unknown)2012-02-01Date precision: month

Registry last updated2017-02-14

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Chronic Obstructive Pulmonary Disease With (Acute) Exacerbationunresolved

Interventions

RoflumilastDRUG

PlaceboDRUG

Sponsors & collaborators

AstraZenecalead sponsor

Mapped research locations

LondonUnited Kingdom2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01473758 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.